logo
logo

Obviohealth Raises $31 Million, Adds Two Strategic Partners To Bolster Capabilities And Drive Growth Globally

Jul 01, 2021•about 4 years ago

Amount Raised

$31 Million

Description

ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million in its latest round of financing. The round was led by two new partners: Dedalus Group, an international healthcare IT and diagnostic software provider, leader in Europe and backed by Ardian, and Novotech Health Holdings Pte. Ltd. ("Novotech"), Asia Pacific's highest revenue biotech-specialist CRO in 2020.

Company Information

Company

Obvio Health

About

ObvioHealth is an end-to-end Virtual Research Organization (VRO) that delivers better data to sponsors and an easier clinical trial experience for participants. The company developed and launched one of the first DCT apps, downloadable on smartphones enabling people to participate in clinical trials from the comfort of their homes. In the 4 years since launch, the company has been awarded nearly 40 studies from 28 blue chip clients, implemented in 28 countries, in 16 different therapeutic areas. For more information, visit https://www.obviohealth.com.

Related People

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech